Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Arrow Group (Abbreviated New Drug Applications)

M&A STATUS
Asset Purch. LATEST DEAL TYPE
1 FINANCING ROUNDS
Description

Rights to Abbreviated New Drug Applications. It includes ANDA for Cabergoline from Watson and ANDA for Dronabinol from Cobalt Pharmaceuticals.

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Other Pharmaceuticals and Biotechnology
Primary Office
  • Clonshaugh Business and Technology Park
  • Coolock
  • Dublin D17 E400
  • Ireland

Arrow Group (Abbreviated New Drug Applications) Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Arrow Group (Abbreviated New Drug Applications)‘s full profile, request access.

Request full access to PitchBook

Arrow Group (Abbreviated New Drug Applications) Former Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore Arrow Group (Abbreviated New Drug Applications)‘s full profile, request access.

Request full access to PitchBook